Recent Articles from Investor's Business Daily
The Pentagon is undertaking a review of all major defense contractors. Those considered to be habitually late will be punished.
Via Investor's Business Daily · February 11, 2026
Cisco stock fell amid fiscal Q2 earnings and revenue that topped estimates while the company's April quarter revenue outlook came in above views.
Via Investor's Business Daily · February 11, 2026
Bank of Hawaii, Western Alliance and Beacon Financial launched into a blistering start to 2026. So has the SPDR S&P Regional Banking ETF.
Via Investor's Business Daily · February 11, 2026
The lithium producer has run up since April on surging prices.
Via Investor's Business Daily · February 11, 2026
The company is hoping to take on Amgen's Tezspire in asthma treatment.
Via Investor's Business Daily · February 11, 2026
Generac sees data center opportunities. The S&P 500 stock is up around 34% in 2026.
Via Investor's Business Daily · February 11, 2026
Amazon makes BETA Technologies its second-largest holding in Q4. Air taxi, eVTOL maker vaults, shares upgraded.
Via Investor's Business Daily · February 11, 2026
Tesla's valuation is roughly 14 times that of BYD's, even though BYD recently surpassed Tesla as the world's top electric-vehicle company.
Via Investor's Business Daily · February 11, 2026
Shopify revenue and guidance topped expectations. The e-commerce software firm also set a $2 billion buyback.
Via Investor's Business Daily · February 11, 2026
Vertiv stock also gapped up on its 2026 outlook.
Via Investor's Business Daily · February 11, 2026
The Federal Reserve sees a stabilizing job market. January data could show otherwise.
Via Investor's Business Daily · February 11, 2026
Tower Semiconductor beat consensus estimates for the fourth quarter and with its guidance for the current period. But TSEM stock fell.
Via Investor's Business Daily · February 11, 2026
Household and kitchen appliance maker SharkNinja beat Wall Street's targets for the fourth quarter and announced its first stock buyback.
Via Investor's Business Daily · February 11, 2026
The Relative Strength (RS) Rating for Axcelis Technologies stock entered a new percentile Wednesday, with an increase from 70 to 81.
Via Investor's Business Daily · February 11, 2026
Beazer Homes stock had its Relative Strength Rating upgraded to 74 Wednesday — a nice improvement, but shy of the 80-plus score you look for.
Via Investor's Business Daily · February 11, 2026
InterContinental operates 6,845 hotels globally, and recently passed the 1 million rooms mark. IHG stock got a rating upgrade Wednesday.
Via Investor's Business Daily · February 11, 2026
The FDA rejected Moderna's experimental flu vaccine Tuesday in a move that could be a blow to recently hot Moderna stock.
Via Investor's Business Daily · February 10, 2026
Lattice Semiconductor matched Wall Street's earnings target on higher-than-expected sales in the fourth quarter. LSCC stock rose late.
Via Investor's Business Daily · February 10, 2026
Astera Labs topped estimates for the fourth quarter and with its Q1 guidance. But ALAB stock fell on the hiring of a new CFO.
Via Investor's Business Daily · February 10, 2026
Cloudflare stock popped amid Q4 earnings and revenue that topped Wall Street targets while the company's 2026 revenue outlook came in above views.
Via Investor's Business Daily · February 10, 2026
Edwards Lifesciences stock was little changed late Tuesday after earnings missed forecasts but fourth-quarter sales beat.
Via Investor's Business Daily · February 10, 2026
Chip-gear maker Advanced Energy Industries crushed Wall Street's targets for the fourth quarter and with its outlook. AEIS stock rose late.
Via Investor's Business Daily · February 10, 2026
Gilead Sciences cleanly beat fourth-quarter expectations late Tuesday, but Gilead stock could take a hit on its light outlook.
Via Investor's Business Daily · February 10, 2026
Altruist reveals an AI tax planning tool for wealth advisors, clients. Charles Schwab, Raymond James and related stocks tumbled Tuesday.
Via Investor's Business Daily · February 10, 2026
UBS analysts called the conglomerate an attractive defensive play.
Via Investor's Business Daily · February 10, 2026
Daiwa upgraded Palantir stock to buy on views the data analytics software maker is winning bigger artificial intelligence contracts.
Via Investor's Business Daily · February 10, 2026
When T-Mobile reports Q4 earnings and hosts an investor day on Wednesday, rivals AT&T and Verizon will be focused on its 2026 guidance.
Via Investor's Business Daily · February 10, 2026
Marriott stock hit new highs Tuesday. The company's outlook seemed to overshadow a fourth-quarter profit that narrowly missed analysts' estimates.
Via Investor's Business Daily · February 10, 2026
Paramount submitted a new offer for Warner Bros. that added clauses meant to demonstrate its belief it could close the deal quickly.
Via Investor's Business Daily · February 10, 2026
Chip foundry Taiwan Semiconductor Manufacturing reported strong sales growth in January. TSM stock hit a record high on the news.
Via Investor's Business Daily · February 10, 2026
The company expects strong Jakafi sales in 2026, but another element of its outlook slammed the stock Tuesday.
Via Investor's Business Daily · February 10, 2026
One glaring problem slammed Medpace stock early Tuesday.
Via Investor's Business Daily · February 10, 2026
Oracle stock was slightly higher Tuesday after starting the week with its best trading day in five months.
Via Investor's Business Daily · February 10, 2026
AstraZeneca stock rose moderately Tuesday morning on better-than-expected sales and profit in the fourth quarter.
Via Investor's Business Daily · February 10, 2026
The company is looking to take on Regeneron and Sanofi's blockbuster, Dupixent, in eczema treatment.
Via Investor's Business Daily · February 10, 2026
Robinhood reports Q4 results late Tuesday amid booming prediction markets popularity. But crypto has fallen into bear market territory.
Via Investor's Business Daily · February 10, 2026
Nuclear S&P 500 component Vistra rose before the stock market open on Tuesday as analysts see upside.
Via Investor's Business Daily · February 10, 2026
2026 revenue guidance was better than feared. Investor Day is on Feb. 12.
Via Investor's Business Daily · February 10, 2026
Semiconductor equipment supplier Entegris topped estimates for the fourth quarter and with its outlook. Entegris stock rose.
Via Investor's Business Daily · February 10, 2026
Streaming music leader Spotify Technology beat estimates for subscribers and total users in the fourth quarter. Spotify stock jumped.
Via Investor's Business Daily · February 10, 2026
Analyst consensus is for a 59% leap in DT Midstream EPS to $1.16 this quarter on a 28% rise in revenue to $316.3 million.
Via Investor's Business Daily · February 10, 2026
LiDAR sensing systems maker Aeva Technologies stock had its Relative Strength (RS) Rating upgraded from 89 to 92 Tuesday.
Via Investor's Business Daily · February 10, 2026
Lidar sensor maker Ouster stock had its Relative Strength (RS) Rating upgraded 77 to 83 Tuesday, up from 77 a day earlier.
Via Investor's Business Daily · February 10, 2026
On Semiconductor offered a soft sales forecast for the first quarter after an in-line Q4. Onsemi stock fell late.
Via Investor's Business Daily · February 9, 2026
The $1 billion initial public offering of Clear Street Group leads several IPOs scheduled this week as the new issues market heats up.
Via Investor's Business Daily · February 9, 2026
Boeing and Curtiss-Wright rose on an Air Force modernization contract as President Trump revealed a foreign military sales executive order.
Via Investor's Business Daily · February 9, 2026
AppLovin stock is regaining some ground after an analyst called recent fears driving a sell-off for the advertising technology company.
Via Investor's Business Daily · February 9, 2026
BYD alleged the U.S. laws used to justify the Trump administration's trade crackdown do not include tariffs.
Via Investor's Business Daily · February 9, 2026
STMicroelectronics on Monday announced an expanded supply agreement with Amazon Web Services. STM stock jumped on the news.
Via Investor's Business Daily · February 9, 2026
Google-parent Alphabet plans a $15 billion bond sale as it continues to add debt amid massive capital spending spurred by artificial intelligence.
Via Investor's Business Daily · February 9, 2026
Hims stock crashed Monday after Novo Nordisk filed a lawsuit, claiming the online pharmacy is "deceiving patients."
Via Investor's Business Daily · February 9, 2026
Kroger stock advanced on Monday after announcing its new CEO is former Walmart executive Greg Foran.
Via Investor's Business Daily · February 9, 2026
Oracle stock was upgraded to a buy rating from analysts at DA Davidson on Monday, who are more positive on a "revamped" OpenAI.
Via Investor's Business Daily · February 9, 2026
Morgan Stanley initiates coverage of bitcoin miners TeraWulf, Cipher Mining, MARA. Cathie Wood, ARK buy Bullish, sell Coinbase.
Via Investor's Business Daily · February 9, 2026
Workday stock fell after the software maker announced that co-founder Aneel Bhusri will return as chief executive officer, replacing Carl Eschenbach.
Via Investor's Business Daily · February 9, 2026
Dynatrace stock climbed after Dynatrace earnings for fiscal Q3 topped estimates and guidance came in above views.
Via Investor's Business Daily · February 9, 2026
Google has signed solar power purchase agreements with TotalEnergies. The energy will be used for Texas data centers.
Via Investor's Business Daily · February 9, 2026
AI stocks have been volatile in 2026 amid hyperscaler capital spending hikes, with software stocks hammered. But there are bright spots.
Via Investor's Business Daily · February 9, 2026
Monday.com topped Q4 estimates but shares dived on its 2026 revenue outlook.
Via Investor's Business Daily · February 9, 2026
Read inspirational quotes about extending success in life, mastering change and hoping for better times ahead.
Via Investor's Business Daily · February 9, 2026
The Relative Strength (RS) Rating for RXO stock moved up into a new percentile Monday, as it got a lift from 66 to 74.
Via Investor's Business Daily · February 9, 2026
In a welcome move, Broadcom stock saw its Relative Strength (RS) Rating improve to 79 on Monday, up from 70 a day earlier.
Via Investor's Business Daily · February 9, 2026
Arista Networks shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Via Investor's Business Daily · February 9, 2026
Backed down under FDA pressure two days after launching the weight-loss pill.
Via Investor's Business Daily · February 7, 2026
This diverse group made bullish moves last week, mostly on Friday.
Via Investor's Business Daily · February 7, 2026
In 2001, Pixar was preparing to release the film "Finding Nemo." Given Pixar's track record of blockbusters, everyone expected another hit.
Via Investor's Business Daily · February 6, 2026
Microsoft stock has been laid low by concerns about the potential negative impact of artificial intelligence on the software sector.
Via Investor's Business Daily · February 6, 2026
A Wall Street analyst upgraded Roku stock to buy from neutral ahead of the streaming video platform's fourth-quarter earnings report.
Via Investor's Business Daily · February 6, 2026
The Nasdaq and S&P 500 broke support but many sectors are thriving.
Via Investor's Business Daily · February 6, 2026
S&P 500 health insurer Molina Healthcare crashed amid surging health benefit costs. Molina and Centene both expect big drops in ACA enrollment.
Via Investor's Business Daily · February 6, 2026
Roivant Sciences unveiled "exceptional" results Friday for its skin disease treatment, sending the biotech stock flying.
Via Investor's Business Daily · February 6, 2026
Cathie Wood, ARK Invest add to Bullish holdings after the crypto exchange's Q4 report, sells Coinbase. Bitcoin attempts to claw back losses.
Via Investor's Business Daily · February 6, 2026
U.S.-based biotech stocks are closely watching the advance of China into the biotech segment. Will they withstand the rivalry?
Via Investor's Business Daily · February 6, 2026
Palantir's 2026 sell-off likely isn't over says a Jefferies analyst. Here's why.
Via Investor's Business Daily · February 6, 2026
Biogen topped fourth-quarter expectations Friday, thanks to far better-than-expected sales of a multiple sclerosis drug.
Via Investor's Business Daily · February 6, 2026